Document Detail

Beneficial effects of statins after percutaneous coronary intervention.
MedLine Citation:
PMID:  19369875     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Evidence about the efficacy of statin treatment among patients after percutaneous coronary intervention (PCI) is very limited. The rapid advancement in PCI technology and near universal use of adjunctive cardioprotective medications make it necessary to formally assess the effect of statin therapy on cardiac events after PCI.
DESIGN: This was a multicenter prospective cohort study.
METHODS: Patients who received stent implantation and survived to hospital discharge from the National Heart, Lung, and Blood Institute Dynamic Registry from 2004 to 2006 formed the study cohort. Patients with cardiogenic shock, in-hospital adverse events [including myocardial infarction and coronary artery bypass graft surgery (CABG)], liver disease, renal disease, alcoholism, or drug abuse were excluded. The occurrences of death, CABG, and repeat PCI, and repeat revascularization were collected over 1-year follow-up.
RESULTS: Of the 3227 patients evaluated, 2737 (85%) were prescribed a statin at discharge. By 1-year follow-up, incident events were 98 deaths, 44 CABG, 290 repeat PCI procedures, and 328 repeat revascularizations. After propensity score adjustment, postdischarge statin therapy was associated with lower risks of death [hazard ratio (HR): 0.58, 95% confidence interval (CI): 0.36-0.93, P = 0.02], CABG (HR: 0.49, 95% CI: 0.24-1.00, P = 0.05), and repeat revascularization (HR: 0.74, 95% CI: 0.56-1.00, P = 0.05).
CONCLUSION: These results support the routine use of statin therapy after PCI.
Zhi-Jiang Zhang; Oscar C Marroquin; Joel L Weissfeld; Roslyn A Stone; Suresh R Mulukutla; David O Williams; Faith Selzer; Kevin E Kip
Related Documents :
25099475 - Epidemiology and clinical profile of takotsubo cardiomyopathy.
18004115 - Relationship of admission haematological indices with infarct-related artery patency in...
23105645 - Biochemical markers of myocardial injury.
23614585 - Biventricular pacing for atrioventricular block and systolic dysfunction.
16636615 - Csf shunt failure with stable normal ventricular size.
7633915 - Paracrine modulation of coronary vasomotor tone and myocardial performance by vascular ...
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology     Volume:  16     ISSN:  1741-8275     ISO Abbreviation:  Eur J Cardiovasc Prev Rehabil     Publication Date:  2009 Aug 
Date Detail:
Created Date:  2009-07-30     Completed Date:  2009-10-29     Revised Date:  2013-06-02    
Medline Journal Info:
Nlm Unique ID:  101192000     Medline TA:  Eur J Cardiovasc Prev Rehabil     Country:  England    
Other Details:
Languages:  eng     Pagination:  445-50     Citation Subset:  IM    
Department of Epidemiology, School of Public Health, Shanghai Jiao Tong University, Shanghai, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chi-Square Distribution
Combined Modality Therapy
Coronary Disease / therapy*
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Linear Models
Middle Aged
North America
Proportional Hazards Models
Prospective Studies
Survival Rate
Grant Support
HL-33292/HL/NHLBI NIH HHS; U01 HL033292-15/HL/NHLBI NIH HHS; U01 HL033292-16/HL/NHLBI NIH HHS; U01 HL033292-17/HL/NHLBI NIH HHS; U01 HL033292-18/HL/NHLBI NIH HHS; U01 HL033292-19/HL/NHLBI NIH HHS; U01 HL033292-20/HL/NHLBI NIH HHS; U01 HL033292-21/HL/NHLBI NIH HHS; U01 HL033292-22/HL/NHLBI NIH HHS; U01 HL033292-23/HL/NHLBI NIH HHS
Reg. No./Substance:
0/Hydroxymethylglutaryl-CoA Reductase Inhibitors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Impact of different diagnostic criteria on the prevalence and prognostic significance of exertional ...
Next Document:  Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular eve...